📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
21
BVNRY Latest News & AI Sentiment Analysis
2 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 8 ARTICLES
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
Bavarian Nordic achieved significant regulatory milestone with European Commission approval to expand IMVANEX (MVA-BN) vaccine labeling...
Protean Funds Scandinavia AB July 2026 Partner Letter
Protean Funds Scandinavia AB's small-cap strategy generated a 5.4% return in July, exceeding its benchmark by 170 basis points. This...
Bavarian Nordic - Completion of Share Buy-Back Program
Bavarian Nordic (BVNRY) has completed its third and final share buyback tranche in 2026, purchasing approximately DKK 150 million in...
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program
Bavarian Nordic (BVNRY) has announced execution of a share repurchase program totaling DKK 150 million (~USD 20 million equivalent),...
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program
Bavarian Nordic (trading as BVNRY on US exchanges) announced execution of a share repurchase program authorized on June 2, 2026, with a...
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
Bavarian Nordic (BVNRY, BVNKF) secured Canadian regulatory clearance for VIMKUNYA®, its recombinant chikungunya vaccine, expanding its...
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program
Bavarian Nordic (BVNRY) announced execution of its DKK 150 million share repurchase program initiated on June 2, 2026, with completion...
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program
Bavarian Nordic (BVNRY) has announced a routine share repurchase program targeting up to DKK 150 million (~USD 20 million equivalent)...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice